Press releases | WebDisclosure

Basculer en Français

11294	Companies
250991	Keywords
179910	Articles
136856	Press releases

Home
Press releases

PRESS RELEASE

published on 08/28/2026 at 11:15, 2 months 11 days ago

Redcare Pharmacy announces Managing Board succession: Peter Schmid von Linstow to succeed Olaf Heinrich as part of a planned leadership transition.
Redcare Pharmacy announces Managing Board succession: Peter Schmid von Linstow to succeed Olaf Heinrich as part of a planned leadership transition

Leadership Transition Redcare Pharmacy Olaf Heinrich Peter Schmid Von Linstow Managing Board Succession
PRESS RELEASE

published on 08/28/2026 at 11:12, 2 months 11 days ago

EQS-Adhoc: Redcare Pharmacy N.V.: Change in the Managing Board; Peter Schmid von Linstow to become Chief Executive Officer.
Redcare Pharmacy N.V. appoints Peter Schmid von Linstow as new CEO, replacing Olaf Heinrich. Heinrich to stay on in advisory role. Announcement made by Supervisory Board

CEO Appointment Supervisory Board Redcare Pharmacy N.V. Executive Board Change Advisory Role
PRESS RELEASE

published on 08/28/2026 at 11:00, 2 months 11 days ago

Warren Wise Unravels the Rheinmetall Paradox – Defense Boom Without a Share Price Rally
Warren Wise investigates Rheinmetall's defense boom but falling share price, analyzing company's economic moat, transparency, and valuation factors. Podcast available at warren-wise.com

Share Price Rheinmetall Warren Wise Economic Moat Defense Boom
PRESS RELEASE

published on 08/28/2026 at 10:58, 2 months 11 days ago

High approval at the Annual General Meeting – Shareholders confirm the course of Netfonds AG
High approval at the Annual General Meeting as Netfonds AG shareholders confirm company course. Detailed financial year report presented by CEO and CFO

Annual General Meeting Shareholders Netfonds AG Financial Industry Approval
PRESS RELEASE

published on 08/28/2026 at 10:55, 2 months 11 days ago

Heidelberg Pharma and Huadong Medicine Sign Additional Collaboration Agreement to Jointly Develop New Antibody Drug Conjugates
Heidelberg Pharma and Huadong Medicine sign new collaboration agreement to jointly develop Antibody Drug Conjugates, expanding pipeline with innovative products

Heidelberg Pharma ADC Technology Antibody Drug Conjugates Collaboration Agreement Huadong Medicine
PRESS RELEASE

published on 08/28/2026 at 10:48, 2 months 11 days ago

EQS-Adhoc: Heidelberg Pharma and Huadong Medicine Sign Additional Collaboration Agreement to Jointly Develop New Antibody Drug Conjugates
Heidelberg Pharma and Huadong Medicine sign a new collaboration agreement to jointly develop new Antibody Drug Conjugates, broadening their existing partnership and combining proprietary technologies

Heidelberg Pharma ADC Technology Antibody Drug Conjugates Collaboration Agreement Huadong Medicine
PRESS RELEASE

published on 08/28/2026 at 10:39, 2 months 11 days ago

Eramet : Bilan semestriel du contrat de liquidité au 30 juin 2026
ERAMET publie son bilan semestriel de contrat de liquidité pour le 1er semestre 2026, avec détails des transactions d'achat et de vente de titres

Contrat De Liquidité Bilan Semestriel Transactions Titres Eramet
PRESS RELEASE

published on 08/28/2026 at 10:10, 2 months 11 days ago

XCMG Unveils World's First 14,000-Ton Ring Crane, Redefining Ultra-Heavy Lifting
XCMG unveils the world's first 14,000-ton ring crane, revolutionizing ultra-heavy lifting with innovative technology and energy-saving features

Innovation Energy-saving Ultra-heavy Lifting 14,000-ton Ring Crane XCMG
PRESS RELEASE

published on 08/28/2026 at 10:06, 2 months 11 days ago

PLAN-B NET ZERO scales technology platform with additional PaaS customer
PLAN-B NET ZERO expands technology platform with new PaaS customer, driving scaling of neo-energy model. Additional connections increase platform reach and user base

Technology Platform Scalability PLAN-B NET ZERO PaaS Customer Neo-energy Model
PRESS RELEASE

published on 08/28/2026 at 10:00, 2 months 11 days ago

iFX EXPO LATAM Evolves into The Trading Festival Mexico for 2026
Mexico City, Mexico, August 28th, 2026, FinanceWire

Accesswire

Published on 11/06/2026 at 22:15, 2 days 9 hours ago

Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 19 hours ago

Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 19 hours ago

Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 19 hours ago

Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 10:00, 2 days 22 hours ago

Mongolia Tax Audit

View all ACCESSWIRE

EQS Group

Published on 11/09/2026 at 07:30, 38 minutes ago

Hannover Re increases Group profit and confirms full-year guidance
Published on 11/09/2026 at 07:30, 39 minutes ago

SUSS Expands Photomask Portfolio with Next-Generation ASC9500 Mid-End Cleaner
Published on 11/09/2026 at 07:30, 39 minutes ago

GEA delivers strong third quarter: order intake rises substantially, revenue and profitability further improved
Published on 11/09/2026 at 07:30, 39 minutes ago

Nordex Group to enter Albania with 84 MW order from Verbund
Published on 11/09/2026 at 07:30, 39 minutes ago

q.beyond posts high volume of one-off charges in Q3 2026 – restructuring set to pay off from 2027 onwards

Les Echos

Published on 11/09/2026 at 07:00, 1 hour 9 minutes ago

bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 1 hour 9 minutes ago

BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Published on 11/09/2026 at 07:00, 1 hour 9 minutes ago

Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine
Published on 11/09/2026 at 07:00, 1 hour 9 minutes ago

bioMérieux obtient l’autorisation 510(k) de la FDA américaine pour les dernières versions des tests BIOFIRE® FILMARRAY® Gastrointestinal Panels afin d’optimiser la détection des pathogènes gastrointestinaux, dont le norovirus
Published on 11/06/2026 at 19:06, 2 days 13 hours ago

ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026

View all LES ECHOS COMFI WIRE